Summary
Treatment with twice-weekly tacrolimus ointment in patients with moderate to severe atopic dermatitis: Results from two randomized, multicentre, comparative studies
Summary
Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: Clinical efficacy and economic impact over 12 months
Summary
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: Findings from the protopic CONTROL study
Summary
Outcomes and cost of proactive use of tacrolimus 0.03% ointment in children with moderate or severe atopic dermatitis
Summary
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: A health-economic model simulation based on a patient survey and clinical trial data